Clinical Trials
7 trialsNCT07526493 2026-05-12
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Tongji Hospital
Phase 1 Recruiting
NCT07085676 2026-05-06
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Hadassah Medical Organization
Phase 1 Recruiting
NCT02450396 2026-03-27
EGR2
Assistance Publique - Hôpitaux de Paris
Withdrawn
NCT07333196 2026-01-21
Tongji NADs Cohort
Tongji Hospital
Not yet recruiting
NCT07249060 2025-12-03
INTER-AUTENTIC
Hospital Universitario Araba
Recruiting
NCT02422875 2025-09-30
Comparative Autoantibody and Immunologic Cell Marker Study
Emory University
Enrolling by invitation
NCT07022197 2025-06-15
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Tianjin Medical University General Hospital
Phase 1/2 Recruiting